You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
Access to health is essential to everyone. Unfortunately, many people around the world face various barriers that limit their ability to access the healthcare they need.
Astellas recognizes Access to Health as a materiality, and through our VISION to be "On the forefront of healthcare change to turn innovative science into VALUE for patients", we are proactively taking a comprehensive approach to solving this issue through the methods defined below.
Astellas continues to contribute to the health of patients by researching, developing, and delivering innovative healthcare solutions to address diseases with high unmet medical needs ( (1) Astellas’ core business(Rx, Rx+)).
For patients who are unable to receive appropriate medical care for socioeconomic reasons, we have established comprehensive Access to Medicine mechanism to enhance the availability of Astellas therapies while taking into consideration the situation and regulations in each country ( (2) Enhancing availability of Astellas products (Access to Medicines).
In addition, Astellas is tackling more diverse issues of Access to Health by collaborating with and supporting the activities of external partners while leveraging our capabilities and technologies ( (3) Collaboration and support for the activities implemented by external partners to improve Access to Health).
Since our establishment, Astellas has continuously strived to create innovative healthcare solutions and deliver them to patients who need them. We will accelerate our research and development based on our Focus Area approach and create diverse healthcare solutions by combining innovative biologies and modalities/technologies. In addition, our Rx+® business leverages Astellas’ expertise and knowledge to integrate innovative medical technology with cutting-edge technology in different fields, throughout the patient journey (overall medical care, including diagnostic, preventive, therapeutic and prognostic care).
Click here to learn more about Astellas' core business (Rx, Rx+)
There are patients around the world who, for socioeconomic reasons, have difficulty accessing Astellas therapies. Astellas is committed to enhancing the availability of our products at all stages of the product lifecycle: during clinical research, development, and ultimately, bringing the therapy to market. For example, we offer “Support programs” for patients who cannot afford the cost of medication; “Early access programs” to provide our investigational therapies to patients outside of the clinical trial setting and “International pharmacy,” which can facilitate access to certain Astellas therapies in countries where the therapy is not yet approved. We will enhance the availability of Astellas therapies while taking into consideration the characteristics of each measures and regulations in each country.
Click here to learn more about enhancing availability of Astellas products (Access to Medicines)
In addressing the issues of Access to Health, Astellas promotes collaboration with external partners and support for their activities by leveraging Astellas' capabilities and technologies. In the search for drugs to treat tuberculosis, Astellas is continuing to conduct research with external research institutions, utilizing multiple hit compounds* obtained from the joint research (“Screening PJ”) for the exploration of new compounds for Mycobacterium tuberculosis. Furthermore, within a consortium of partners, Astellas is providing its formulation technology to develop a pediatric formulation of praziquantel, a standard treatment for schistosomiasis. In the area of strengthening health systems and improving healthcare literacy, we are funding new projects with external organizations to impact society where anticipates synergy with Astellas sustainability.
The Astellas Global Health Foundation supports the most underserved communities in low and middle income countries where Astellas does not have a business presence. Astellas provides support to the Astellas Foundation for Research on Metabolic Disorders, which awards grants for research initiatives. These initiatives contribute to medical and life sciences by supporting the development and discovery of the next generation of researchers through training and an opportunity to study abroad.
For details, please visit the following website,
Global Health and Social Impact
Astellas Global Health Foundation
∗Hit compound: A compound with a physiological activity that meets the predefined criteria discovered through compound screening (search for drug discovery seeds).
